Loading organizations...
Chemo, the industrial division of Insud Pharma, specializes in the research, development, and manufacturing of active pharmaceutical ingredients and finished dosage forms. It provides components and products to the global pharmaceutical industry, using a technical approach that integrates scientific innovation with robust production to ensure quality and reliable supply.
Established in 1977, the company was founded by Psychiatrist Hugo Sigman and Biochemist Silvia Gold. Their vision centered on building a pharmaceutical enterprise with strong industrial foundations, utilizing their diverse expertise to guide its early growth and strategic development.
Chemo serves pharmaceutical manufacturers worldwide, supplying essential materials and finished medicines. Its mission, aligned with Insud Pharma, focuses on advancing global health by continuously developing and delivering high-quality pharmaceutical solutions. The company remains committed to research and improving patient access to vital medications globally.
Chemo Group has 1 tracked investment across 1 company. The latest tracked deal is $8.0M Series A in Babyscripts in July 2017.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Jul 1, 2017 | Babyscripts | $8.0M Series A | Carlos Gallardo | Acrew Capital, Amino Capital, Cathay Innovation, Clocktower Technology Ventures, DST Global, Forerunner Ventures, Homebrew, Inspired Capital, Menlo Ventures, Motivate Ventures, Outcast Ventures, PivotNorth Capital, Vitalize Venture Group, Kevin Colas, SUE XU, Zander Lurie, Advocate Aurora Enterprises, CG Health Ventures, P5 Health Ventures |